BAROZZI, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.852
EU - Europa 6.732
AS - Asia 2.219
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 19
AF - Africa 6
OC - Oceania 6
Totale 23.871
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.778
GB - Regno Unito 2.715
IT - Italia 1.320
SE - Svezia 860
CN - Cina 743
SG - Singapore 603
DE - Germania 500
UA - Ucraina 371
HK - Hong Kong 346
TR - Turchia 296
FI - Finlandia 269
FR - Francia 168
RU - Federazione Russa 157
BG - Bulgaria 145
IN - India 75
CA - Canada 48
BE - Belgio 43
ID - Indonesia 39
CZ - Repubblica Ceca 34
IR - Iran 33
NL - Olanda 33
IE - Irlanda 27
BZ - Belize 26
BR - Brasile 22
KR - Corea 20
VN - Vietnam 18
EU - Europa 16
LT - Lituania 16
MY - Malesia 13
JP - Giappone 12
RO - Romania 12
PL - Polonia 10
ES - Italia 8
AT - Austria 6
AU - Australia 6
CL - Cile 6
CH - Svizzera 5
GR - Grecia 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
PT - Portogallo 4
AR - Argentina 3
CY - Cipro 3
MD - Moldavia 3
PE - Perù 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
CO - Colombia 2
EE - Estonia 2
IL - Israele 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
RS - Serbia 2
A1 - Anonimo 1
AZ - Azerbaigian 1
EC - Ecuador 1
EG - Egitto 1
GN - Guinea 1
IM - Isola di Man 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
NO - Norvegia 1
PH - Filippine 1
SD - Sudan 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 23.871
Salva come PNG Salva come JPEG
Città #
Southend 2.310
Fairfield 1.976
Santa Clara 1.527
Woodbridge 1.279
Ashburn 1.055
Chandler 955
Houston 944
Ann Arbor 820
Jacksonville 779
Seattle 729
Wilmington 679
Dearborn 655
Cambridge 588
Nyköping 504
Singapore 447
Hong Kong 343
Modena 264
Beijing 195
Izmir 187
New York 182
San Diego 156
Princeton 149
Sofia 142
Eugene 139
Helsinki 136
Fremont 89
Milan 89
Moscow 73
Bremen 71
Des Moines 70
London 63
Rome 55
San Jose 50
Redwood City 48
Boardman 46
Bologna 44
Brussels 40
Jakarta 39
Chicago 38
Shanghai 36
Dallas 35
Philadelphia 33
Albuquerque 32
Hefei 32
Belize City 26
Dublin 26
Munich 26
Ottawa 26
Las Vegas 23
Nanjing 22
Norwalk 22
Leawood 21
Kunming 20
San Mateo 20
Toronto 19
Tulare 19
Verona 19
Guangzhou 17
Kilburn 16
Reggio Emilia 16
Saint Louis 16
Chiswick 15
Naples 15
Columbus 14
Dong Ket 14
Brno 13
Falls Church 13
Jinan 13
Paris 13
Parma 13
Bangalore 12
Washington 12
Auburn Hills 11
Bari 11
Saint Petersburg 11
Hounslow 10
Nanchang 10
Seongnam 10
Los Angeles 9
Pavia 9
Perugia 9
San Francisco 9
Tokyo 9
Turin 9
Istanbul 8
Romainville 8
Ardabil 7
Augusta 7
Castelnuovo Di Porto 7
Florence 7
Fuzhou 7
Prescot 7
Wuhan 7
Acton 6
Amsterdam 6
Andover 6
Atlanta 6
Changsha 6
Dongguan 6
Frankfurt am Main 6
Totale 18.848
Salva come PNG Salva come JPEG
Nome #
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 296
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 283
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 279
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 258
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 257
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 254
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 251
HHV-6A in syncytial giant-cell hepatitis 249
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 244
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 243
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 238
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 237
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 236
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 231
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 227
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 227
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 226
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 223
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 220
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 219
Acute appendicitis in adult neutropenic patients with hematologic malignancies 218
Mucorales-specific T cells in patients with hematologic malignancies 218
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 215
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 214
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 213
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 213
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 212
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 212
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 212
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 211
B cells and herpesviruses: a model of lymphoproliferation 209
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 207
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 205
Translational challenges of human herpesvirus 6 chromosomal integration. 205
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 205
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 205
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 204
Diagnosis of aspergillosis: Role of proteomics 203
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 200
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 197
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 197
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 195
Parvoviruses in blood donors and transplant patients, Italy 194
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 194
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 194
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 192
How I treat HHV8/KSHV-related diseases in posttransplant patients. 190
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 189
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 187
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 187
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 187
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 187
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 184
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 184
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 183
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 182
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 182
Human herpesvirus-8 infection in hemodialysis patients from northern Italy. 181
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 181
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 176
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 174
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 174
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 173
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 173
Human herpesvirus-6 genome in acute lymphoblastic leukemia: Evidence against an etiologic relationship 171
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 169
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 168
HUMAN HERPESVIRUS-6 - A SURVEY OF PRESENCE AND DISTRIBUTION OF GENOMIC SEQUENCES IN NORMAL BRAIN AND NEUROGLIAL TUMORS 167
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 166
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 166
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 165
Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation 164
Expression of cell-homologous genes of human herpesvirus-8 in human immunodeficiency virus-negative lymphoproliferative diseases 164
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 162
Polymerase chain reaction detection of human herpesvirus 8 sequences in primary central nervous system lymphomas 161
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 161
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 161
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 159
HHV-8 infection in the transplantation setting: A concern only for solid organ transplant patients? 159
Human herpesvirus 6 infection in normal human brain tissue 157
Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease 157
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 157
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 155
CHARACTERIZATION OF HUMAN HERPESVIRUS-6 GENOMES FROM CASES OF LATENT INFECTION IN HUMAN LYMPHOMAS AND IMMUNE DISORDERS 154
Skin cancers after organ transplantation 154
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 153
KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney 153
Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 153
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 152
Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies 151
Human herpesvirus-6 reactivation in a longitudinal study of two HIV-1 infected patients 151
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 151
Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients 150
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study 150
Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation 150
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 150
Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia 149
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 149
Spontaneous loss of Ph chromosome with maintenance of clonal hemopoiesis in an untreated patient with myeloproliferative disease and a long survival. 148
Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissues from Italian population. 147
Totale 19.170
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.162
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.599 0 0 0 0 0 701 1.058 751 452 176 229 232
2020/20213.551 300 178 267 441 431 228 242 429 168 450 223 194
2021/20222.760 76 381 381 171 57 98 181 136 264 189 505 321
2022/20232.915 391 322 173 284 429 388 75 277 298 36 148 94
2023/20241.938 66 110 137 167 410 206 218 284 35 38 85 182
2024/20252.725 248 71 101 426 1.053 826 0 0 0 0 0 0
Totale 24.153